Identification of novel MyoD gene targets in proliferating myogenic stem cells

Molecular and Cellular Biology

Volumn 22, Issue 17, 2002, Pages 6199-6208

  Wyzykowski, Jeffrey C ^a   Winata, Therry I ^a   Mitin, Natalia ^a   Taparowsky, Elizabeth J ^a   Konieczny, Stephen F ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIN; PENTRAXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; GENE; GENE ACTIVATION; GENE IDENTIFICATION; GENE TARGETING; ID3 GENE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NP1 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; C-REACTIVE PROTEIN; CELL DIVISION; DNA-BINDING PROTEINS; ESTRADIOL; FIBROBLASTS; GENE EXPRESSION PROFILING; GENES, RAS; INHIBITOR OF DIFFERENTIATION PROTEINS; MICE; MICE, INBRED C3H; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOD PROTEIN; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS P21(RAS); RECOMBINANT FUSION PROTEINS; STEM CELLS; SUBTRACTION TECHNIQUE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036333412     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.17.6199-6208.2002     Document Type: Article

References (54)

1. Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis
2. Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression
3. Transcriptional control of muscle development by myocyte enhancer factor-2 (MEF2) proteins
4. Evolution and development of distinct cell lineages derived from somites
5. Targeted inactivation of the muscle regulatory factor gene Myf-5 results in abnormal rib development and perinatal death
6. A novel site for ubiquitination: The N-terminal residue, and not internal lysines of MyoD, is essential for conjugation and degradation of the protein
7. Inhibition of muscle-specific gene expression by Id3: Requirement of the C-terminal region of the protein for stable expression and function
8. Physical and functional interactions between the transcriptional inhibitors Id3 and ITF-2b
9. A dock-work somite
10. Myf5 is a novel early axonal marker in the mouse brain and is subjected to post-transcriptional regulation in neurons
11. The MyoD binding domain contains a recognition code for muscle-specific gene activation
12. + in cerebellar granule cells
13. Sclerotome induction and differentiation
14. Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: A mechanism for lineage determination in myogenesis
15. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD
16. Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain
17. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene
18. Degradation of myogenic transcription factor MyoD by the ubiquitin pathway in vivo and in vitro: Regulation by specific DNA binding
19. Use of a conditional MyoD transcription factor in studies of MyoD trans-activation and muscle determination
20. Consequences of heteromeric interactions among helix-loop-helix proteins
21. Myf-5 revisited: Loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice
22. Biochemical interactions of the neuronal pentraxins
23. Ras p21val inhibits myogenesis without altering the DNA binding or transcriptional activities of the muscle regulatory factors
24. 5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: Evidence for regulatory genes controlling determination
25. Differential interactions of Id proteins with basic helix loop helix transcription factors
26. MyoD is a sequence-specific DNA binding protein requiring a region of myc homology to bind to the muscle creatine kinase enhancer
27. The basic helix-loop-helix transcription factor Mist1 functions as a transcriptional repressor of MyoD
28. Regulation of the mouse desmin gene: Transactivation by MyoD, myogenin, MRF4, and Myf5
29. FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains
30. Identification of MRF4, myogenin, and E12 oligomer complexes by chemical crosslinking and two-dimensional gel electrophoresis
31. E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the 1d3 protein
32. Transcription factor families: Muscling in on the myogenic program
33. Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms
34. Muscle cell differentiation is inhibited by the helix-loop-helix protein Id3
35. Signaling through NFκB is not required for Ras-induced inhibition of skeletal muscle differentiation
36. Cooperative activation of muscle gene expression by MEF2 and myogenic bHLH proteins
37. A new binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins
38. Myogenin gene disruption results in perinatal lethality because of severe muscle defect
39. Mef2: A transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation
40. Know your neighbors: Three phenotypes in null mutants of the myogenic bHLH gene MRF4
41. Molecular mechanisms regulating myogenic determination and differentiation
42. 1 progression by E2A and Id helix-loop-helix proteins
43. CBP/p300 and muscle differentiation: No HaT, no muscle
44. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development
45. MyoD or Myf-5 is required for the formation of skeletal muscle
46. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
47. Neuronal pentraxin, a secreted protein with homology to acute phase proteins of the immune system
48. Phosphorylation of nuclear MyoD is required for its rapid degradation
49. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers
50. Positive autoregulation of the myogenic determination gene MyoD1
51. Fibroblast growth factor and transforming growth factor β repress expression of the myogenic regulatory gene MyoD1
52. Myogenin is required for late but not early aspects of myogenesis during development
53. Differential trans activation associated with the muscle regulatory factors MyoD1, myogenin, and MRF4
54. Inactivation of the myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib abnormalities